Halozyme Therapeutics (NASDAQ:HALO) Stock Rating Reaffirmed by Benchmark themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Recommendation of "Moderate Buy" by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Oak Ridge Investments LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Gallacher Capital Management LLC Buys New Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report)‘s stock had its “market outperform” rating restated by equities research analysts at JMP Securities in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $72.00 target price on the biopharmaceutical company’s stock. JMP Securities’ target price would indicate a potential upside […]